The Joint Corp. · NASDAQ:JYNT
The Joint — Q3 2026 Earnings Presentation
34 slides from The Joint's earnings presentation, Nov 5, 2026
Slide 1: Investor Presentation
Investor Presentation As of September 30, 2026, reported November 5, 2026 NASDAQ: JYNT | © 2026 The Joint Corp. All Rights Reserved. | 1 ‹#›
Slide 2: Safe Harbor Statements
Safe Harbor Statements This presentation contains statements about future events and expectations that constitute forward-looking statements. Forward-looking statements are based on our beliefs, assumptions and expectations of industry trends, our future financial and operating performance and our g
Slide 3: Our Mission
Our Mission OUR MISSION OUR VISION is to improve quality of life is to build America’s most through routine accessible health and affordable chiropractic care. and wellness services company. NASDAQ: JYNT | © 2026 The Joint Corp. All Rights Reserved. | 3
Slide 4: Reasons to Join: Reasons to Invest
Reasons to Join: Reasons to Invest Leading Chiropractic Care Franchise Concept Large & Growing Market New Strategic Attractive Asset-light Model Plan to Strong Recurring Revenue Strengthen Core and Category Leader & Creator Reignite Growth NASDAQ: JYNT | © 2026 The Joint Corp. All Rights Reserved. |
Slide 5: Quality, convenient, affordable chiropractic care in a retail setting
Quality, convenient, affordable chiropractic care in a retail setting Serving patients seeking pain relief and ongoing health and wellness Proven membership-based, walk-in, no-insurance model in an open bay setting NASDAQ: JYNT | © 2026 The Joint Corp. All Rights Reserved. | 5
Slide 6: Strong Operational KPIs
Strong Operational KPIs 14.4M 1.7M 797K 41% 85% adjustments unique patients new patients of new patients were system-wide gross in 2025 treated in 2025 in 2025 new to chiropractic sales from monthly in 20251 memberships in 2025 1 Estimated, based on new patient intake surveys. NASDAQ: JYNT | © 2026
Slide 7: Q3 2026 Year-over-Year Improvements
Q3 2026 Year-over-Year Improvements $13.6M $1.5M $2.3M Total Net Income from Adjusted EBITDA From Revenue Continuing Operations Continuing Operations +1% +$1.2M +$0.9M NASDAQ: JYNT | © 2026 The Joint Corp. All Rights Reserved. | 7
Slide 8: Substantial Market Growth Opportunity
Substantial Market Growth Opportunity The Joint has ~5% of the Out-of-Pocket Share Annual Spending on Chiropractic Care 1 Annual Out-of-Pocket Spending 41.6%2 – 48.7%1 of Total $22.0B $9.2B to $10.7B The Joint ~5% $532.4M System-Wide Sales3 Insurance + Out-of- Other Pocket ~95% Independent & Chain 1
Slide 9: Only 3.4% of Franchise Concepts Have 900+ Units
Only 3.4% of Franchise Concepts Have 900+ Units Percentage of Franchise Brands by # of Units 900+ Units 3.4% 301-900 Units 5.6% 101-300 Units 12.7% 0-50 Units 51-100 Units 68.1% 10.2% Source: FRANdata NASDAQ: JYNT | © 2026 The Joint Corp. All Rights Reserved. | 9
Slide 10: Top Franchise Recognition... Several Years Running
Top Franchise Recognition... Several Years Running #1 Chiropractic Name a Top Brand for #37 of the Services Category Multi-Unit Owners Top 500 #139 in 2025 of the Top 400, up from #150 in 2024. One of the th 6 year breaking top 200 Top 50 Franchises NASDAQ: JYNT | © 2026 The Joint Corp. All Rights R
Slide 11: The Joint: First Mover Advantage
The Joint: First Mover Advantage Companies Clinic Count Insurance Private Pay The Joint Corp.1 930 ✓ Airrosti 160 ✓ ✓ HealthSource Chiropractic 144 ✓ ✓ ChiroOne 107 ✓ ✓ 100% Chiropractic 50 ✓ ✓ Curis Functional Health (Previously The BackSpace) 38 ✓ ✓ NuSpine 29 ✓ ✓ AlignLife Chiropractic 21 ✓ ✓ Chi
Slide 12: Clinic Portfolio
Clinic Portfolio Total Clinics Open at quarter-end 967 960 935 930 125 75 15 1 Franchised 838 135 Company-owned or managed 126 706 96 579 513 64 442 60 885 915 399 48 842 370 800 47 712 312 61 246 47 610 4 515 453 352 394 265 309 242 175 82 12 26 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 202
Slide 13: Growing National Footprint
Growing National Footprint 930 Locations WA 20 MT 1 ND VT NH 3 ME OR MN 915 6 ID 11 MA 10 WI 5 NY SD 10 MI 6 RI WY 8 1 PA CT IA NJ NE 4 4 Franchised Clinics NV 2 5 OH 2 DE UT IL 19 17 IN 1 21 15 MD CO 19 WV 15 34 1 VA 8 KS MO CA KY 19 | 6 8 23 DC 124 | 5 7 NC TN 35 | 2 OK 32 AZ NM 13 AR SC Corporate
Slide 14: A Capital-light, Pure-play Franchisor
A Capital-light, Pure-play Franchisor Strengthened patient engagement and our reshaped operating model helped drive revenue growth and stronger profitability from continuing operations o Growing active membership count and patient retention supported higher patient lifetime value o Comps negative pr
Slide 15: Membership & Patient Metrics
Membership & Patient Metrics • Improved conversion and retention supported active membership count quarter-over-quarter • Gains in lifetime value by increased number of months per active member, and total dollars per active member • Lower average patient spend per month partially offset these benefi
Slide 16: Stronger New Clinic Performance
Stronger New Clinic Performance More Disciplined Development Model is Accelerating Path to Clinic Breakeven, through: Time to Clinic Breakeven Months To Reach Operating Breakeven1 Stronger Partner Selection 1 long-term alignment with proven, efficient multi-unit operators ~18 Months 2 Enhanced Site
Slide 17: Reigniting Growth
Reigniting Growth ✓ Strengthening the foundation for long-term growth, with active membership increasing, and conversion and retention improving ✓ Building on stronger new clinic performance and positive operating trends, which reinforce confidence in a structurally stronger business ✓ Maintaining c
Slide 18: Three Growth Pillars
Three Growth Pillars 1 2 3 Improve Expand Leverage Interest in Comp Sales Clinic Network Longevity & Healthspan • Strengthen patient • Improve new clinic • Use consumer research to acquisition with AI-powered economics, with 2026 personalize the patient lead management and digital openings reaching
Slide 19: Refranchising Efforts
Refranchising Efforts • Once the 15 remaining lease assignments are completed, there will be no remaining company-owned or managed clinics • Benefits of the model are increasingly visible in results • Growth initiatives have better positioned the Company to convert future growth into earnings and ca
Slide 20: Robust Clinic Economics
~$250k - $275k initial build-out Robust Clinic Economics System-wide Sales & Chart includes: Potential 4-Wall Operating Profit1 $571 • 2% of gross sales for the (5 yr. avg., $ in 000s) $535 $530 National Marketing Fund $482 $498 • Local marketing expenses, $455 wages, rent and G&A expenses $415 $391
Slide 21: Updated 2026 Financial Guidance
Updated 2026 Financial Guidance 2026 Financial Guidance 2025 Low High Actual System-wide Sales 1 ($ in Millions) $508 $512 $532.4 Comp Sales 2 (%) (3.5)% (2.5)% (0.4)% Consolidated Adjusted EBITDA (Unchanged) ($ in Millions) $12.5 $13.5 $13.0 Total clinic count at year-end 2026 to be approximately 5
Slide 22: Operating Metrics
Operating Metrics • $123.3M Q3 2026 System-wide Sales 1 (3.1)% vs Q3 2025 • (1.9)% Q3 2026 Comp Sales 2 90 basis-point improvement vs Q2 2026 • $3.3M Q3 2026 Consolidated Adjusted EBITDA In line with Q3 2025 1 System-wide sales include revenues at all clinics, whether operated or managed by the Comp
Slide 23: A Starting Point for Higher Profitability
A Starting Point for Higher Profitability Post-Refranchising Initial / Short-Term Targets Enhanced Near-Term Profitability Royalties & Fees Adj. EBITDA Margin ~10% - 12% of System Sales Near-term 2024 2025 expected run rate Gross Margin 9% 12% ~19% - 21% ~83% - 85% of Revenue G&A Expense Net Income
Slide 24: Capital Allocation
Capital Allocation Growth RD Stock Initiatives Buybacks Repurchases • Balancing system-wide growth, RD territory buybacks and stock repurchases • Improved economics and franchisee support through five RD territory buybacks year-to-date • Returned capital opportunistically; repurchased ~461,000 share
Slide 25: Appendix
Appendix NASDAQ: JYNT | © 2026 The Joint Corp. All Rights Reserved. | 25
Slide 26: Leading Market Growth
Leading Market Growth The Joint 13-yr. CAGR 38% 1 vs. Industry 5-yr. CAGR 2% 2 System-wide Sales ($ in M) People will continue to $530.3 $532.4 $488.0 seek more noninvasive, $435.3 holistic ways to $361.1 manage their pain. $260.0 $220.3 We’ll be there to $165.1 treat them. $98.6 $126.9 $123.3 $70.1
Slide 27: Strong Balance Sheet
Strong Balance Sheet $ in Millions 09/30/26 06/30/26 Unrestricted cash $18.3 $22.2 Restricted cash $1.5 $1.7 Availability on $20M JP Morgan Chase LOC $20.0 $20.0 Provides flexibility to execute our capital allocation framework, while maintaining appropriate liquidity NASDAQ: JYNT | © 2026 The Joint
Slide 28: Third Quarter Results
Third Quarter Results 3 months ended 3 months ended $ in Millions 1 Difference 09/30/26 09/30/25 Revenue $13.6 $13.4 +$0.2 Cost of revenues $2.4 $2.7 ($0.3) Selling and marketing expenses $2.7 $2.8 ($0.1) Depreciation and amortization $0.3 $0.4 ($0.1) G&A expenses $6.9 $7.3 ($0.4) Net income (loss)
Slide 29: Board of Directors
Board of Directors Matthew E. Rubel` Ronald V. DaVella, CPA Christopher M. Grandpre Jeff Gramm Sandi Karrmann Milind Pant Sanjiv Razdan Lead Director, 2017 Director, 2014 Director, 2025 Director, 2024 Director, 2025 Director, 2026 Director, 2024 • Chair, Holley Inc. & Mid Ocean • Financial Advisor,
Slide 30: Executive Team
Executive Team Sanjiv Razdan Scott Bowman Debbie Gonzalez Charles Nelles Craig Sherwood Andra Terrell Ron Stilwell Dr. Steve Knauf SVP, VP of Chiropractic & CEO, Pres. & Dir. CFO CMO CTO SVP & CDO General Counsel & SVP & COO Corporate Secretary Compliance • The Coffee Bean & • Leslie’s Inc. • Concen
Slide 31: Revolutionizing Access to Chiropractic Care
Revolutionizing Access to Chiropractic Care Features Industry Problems The Joint’s Solutions Affordability (per appointment) $76 Average1 $37 Average for 2025 Convenient Locations Medical Centers / Offices Retail Locations Multiple Locations Limited Locations 930 Clinics2 Walk-in / No Appointment Ap
Slide 32: Performance Metrics and Non-GAAP Measures
Performance Metrics and Non-GAAP Measures This presentation includes commonly discussed performance metrics. System-wide sales include revenues at all clinics, whether operated by the company or by franchisees. While franchised sales are not recorded as revenues by the company, management believes t
Slide 33: Quarterly GAAP – Non-GAAP Reconciliation
Quarterly GAAP – Non-GAAP Reconciliation NASDAQ: JYNT | © 2026 The Joint Corp. All Rights Reserved. | 33
Slide 34: Sanjiv Razdan, President & CEO; Scott Bowman, CFO; Richard Land, Investor Relations
Sanjiv Razdan, President & CEO sanjiv.razdan@thejoint.com The Joint Corp. https://www.facebook.com/thejointchiro 16767 N. Perimeter Dr., Suite 110, Scottsdale, AZ 85260 | (480) 245-5960 @thejointchiro Scott Bowman, CFO scott.bowman@thejoint.com https://twitter.com/thejointchiro The Joint Corp. @thej